PFM Health Sciences’s DaVita DVA Stock Holding History

PFM Health Sciences’s Portfolio DVA Stock Details DVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-962,234	Closed	-$49.5M	–	103
2018 Q4	$49.5M	Sell	962,234 -529,592	-35%	-$33.9M	1.32%	30
2018 Q3	$107M	Buy	1,491,826 +206,826	+16%	+$14.6M	1.57%	16
2018 Q2	$89.2M	Buy	1,285,000 +659,997	+106%	+$44.1M	1.4%	19
2018 Q1	$41.2M	Sell	625,003 -585,279	-48%	-$43M	0.84%	48
2017 Q4	$87.4M	Buy	+1,210,282	New	+$74.5M	2.07%	12
2016 Q2	–	Sell	-173,585	Closed	-$12.7M	–	85
2016 Q1	$12.7M	Buy	+173,585	New	+$11.7M	0.39%	59

Other funds holding DVA

Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

GCM

Gates Capital Management New York $4.16B AUM 21% 1-Year Est. Return

PCM

PAR Capital Management Boston, Massachusetts $4.03B AUM 35.05% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

PFM Health Sciences's DVA Position: Q1 2019 in Review

PFM Health Sciences sold out of DaVita (DVA) in Q1 2019, closing a stake of 962,234 shares — an estimated $49.5M sold.

PFM Health Sciences first reported a position in DVA in Q1 2016 and held it in 6 quarters. The position peaked at $107M in Q3 2018. 440 funds tracked by Wall St. Rank hold DVA as of Q1 2019.

PFM Health Sciences reported no remaining DaVita position as of Q1 2019 after selling out during the quarter.
PFM Health Sciences sold 962,234 DaVita shares in Q1 2019, an estimated $49.5M.
PFM Health Sciences first reported a position in DaVita in Q1 2016 and held it in 6 quarters.
PFM Health Sciences's DaVita position peaked at $107M in Q3 2018.
440 funds tracked by Wall St. Rank held DaVita as of Q1 2019.

Based on PFM Health Sciences's 13F filing for Q1 2019, filed 15 May 2019.